Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. INCY
INCY logo

INCY News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

INCY News

Incyte Reports Strong Q1 2026 Earnings with Strategic Growth Plans

3d agoseekingalpha

Incyte Q1 Earnings Exceed Expectations with Strong Revenue Growth

3d agoseekingalpha

Incyte Q1 Earnings Preview and Estimates

4d agoseekingalpha

Minjuvi® Approved in Australia for Relapsed Follicular Lymphoma Treatment

Apr 23 2026Newsfilter

Palvella Appoints New Senior Vice President of Sales

Apr 07 2026Globenewswire

Palvella Appoints New Senior Vice President of Sales

Apr 07 2026Newsfilter

Trump May Announce New Drug Tariffs Soon

Apr 02 2026seekingalpha

Adagene and Incyte Collaborate on Clinical Study for MSS CRC

Apr 02 2026Globenewswire

INCY Events

04/28 07:10
Incyte Appoints Suketu Upadhyay as CFO
Incyte announces the appointment of Suketu Upadhyay as Executive Vice President and Chief Financial Officer, CFO, effective May 4, 2026. In his new role, Upadhyay will serve as a key member of the Executive Leadership Team and lead the Company's global finance organization responsible for Strategic Financial Planning; Capital Allocation; Investor Relations; Finance, Planning and Accounting; Global Sourcing; Environmental, Social, and Governance; Information Technology and Facilities.

INCY Monitor News

Incyte's Zynyz Receives EU Approval for New Cancer Indication

Mar 12 2026

Incyte's Olumiant Receives Positive EMA Opinion for Adolescents

Mar 03 2026

Incyte Reports Q4 Earnings with Revenue Beat but EPS Miss

Feb 10 2026

Incyte Corp reaches 5-day high amid market strength

Feb 06 2026

Incyte's Tafasitamab Trial Shows Promising Results

Jan 08 2026

Incyte's Tafasitamab Trial Achieves Key Milestones

Jan 07 2026

Incyte's Tafasitamab Trial Achieves Key Milestones

Jan 06 2026

Incyte's Minjuvi Receives EC Approval for Lymphoma Treatment

Dec 19 2025

INCY Earnings Analysis

Incyte Q3 2025 Earnings Report: Dynamic Growth & Focus- Intellectia AI™
6 months ago
Promising Product Growth and Robust Pipeline Ahead - Intellectia AI™
1 years ago

People Also Watch